Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The entity indicated as "60S ribosomal protein L10 pseudogene" (ENSG00000250306) is a **pseudogene** corresponding to the functional **60S ribosomal protein L10** gene (RPL10). Pseudogenes are stretches of DNA similar to real genes but are generally considered non-functional and do not encode active proteins. The RPL10 protein is a component of the large, 60S subunit of the ribosome, essential for protein synthesis, but the **pseudogene** itself does not encode a functional protein and thus does not have recognized biological, pathological, therapeutic, or drug interaction roles[3][4]. There is no evidence that this pseudogene is a direct therapeutic target or is associated with known disease mechanisms, functions, or drugs[3]. The functional gene sometimes referred to as RPL10 is distinct and should not be confused with its processed pseudogenes dispersed throughout the genome[1][8]. **Note:** As a pseudogene, this target is not considered a valid therapeutic target, does not have canonical drug interactions, is not implicated directly in biological function, and its inclusion in a target list is likely mistaken or based on error[3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 60S ribosomal protein L10 pseudogene.